Iridium Oxide Hydrate

 

 

SAFETY DATA SHEET

 

 

1   PRODUCT AND SUPPLIER IDENTIFICATION

Product Name:   Iridium Oxide Hydrate

Formula:             IrO2 · 2H2O

Supplier:             ESPI Metals

                            1050 Benson Way

                            Ashland, OR 97520

Telephone:          800-638-2581

Fax:                     541-488-8313

Email:                  This email address is being protected from spambots. You need JavaScript enabled to view it.

Emergency:         Infotrac 800-535-5053 (US) or 352-323-3500 (24 hour)

Recommended Uses:   Scientific Research

 

 

2   HAZARDS IDENTIFICATION

GHS Classification (29 CFR 1910.1200):  Not classified as hazardous

GHS Label Elements: N/A

Hazards Not Otherwise Classified: No further information available

 

 

3   COMPOSITION/INFORMATION ON INGREDIENTS

Ingredient:        Iridium (IV) Oxide Hydrate

CAS#:                 30980-84-8

%:                      100

EC#:                   234-743-9

Common Names and Synonyms: Iridium (IV) oxide dihydrate, iridium dioxide hydrate.

 

 

4   FIRST AID MEASURES

General Measures: Remove patient from area of exposure.

INHALATION: Remove to fresh air, keep warm and quiet, give oxygen if breathing is difficult. Seek medical attention.

INGESTION: Rinse mouth with water. Do not induce vomiting. Seek medical attention. Never induce vomiting or give anything by  mouth to an unconscious person.

SKIN: Remove contaminated clothing, brush material off skin, wash affected area with soap and water. Seek medical attention if symptoms persist.

EYES: Flush eyes with lukewarm water, including under upper and lower eyelids, for at least 15 minutes. Seek medical attention if symptoms persist.

Most Important Symptoms/Effects, Acute and Delayed: May cause irritation. See section 11 for more information.

Indication of Immediate Medical Attention and Special Treatment: No other relevant information available.

 

 

5   FIREFIGHTING MEASURES

Extinguishing Media: Use suitable extinguishing agent for surrounding materials and type of fire.

Unsuitable Extinguishing Media: No information available.

Specific Hazards Arising from the Material: May emit iridium oxide fumes under fire conditions.

Special Protective Equipment and Precautions for Firefighters: Full face, self-contained breathing apparatus and full protective clothing to prevent contact with skin and eyes.

 

 

6   ACCIDENTAL RELEASE MEASURES

Personal Precautions, Protective Equipment, and Emergency Procedures: Wear appropriate respiratory and protective equipment specified in section 8. Isolate spill area and provide ventilation. Avoid contact with skin and eyes. Avoid breathing dust or fume. Eliminate all sources of ignition.

Methods and Materials for Containment and Cleaning Up: Avoid creating dust. Sweep or scoop up. Place in properly labeled closed containers. Scrap can be collected for recycling.

Environmental Precautions: Do not flush to sewer, stream, or other bodies of water. Do not allow to enter drains or to be released to the environment.

 

 

7   HANDLING AND STORAGE

Precautions for Safe Handling: Handle in an enclosed, controlled process. Avoid creating dust. Provide adequate ventilation if dusts are created. Avoid breathing dust or fumes. Avoid contact with skin and eyes. Wash thoroughly before eating or smoking. See section 8 for information on personal protection equipment.

Conditions for Safe Storage, Including Any Incompatibilities: Store in a cool, dry, well-ventilated area. Store in a tightly sealed container. Protect from moisture. See section 10 for more information on incompatible materials.

 

 

8   EXPOSURE CONTROLS AND PERSONAL PROTECTION

Exposure Limits:   OSHA/PEL:                              ACGIH/TLV:

Iridium Oxide           No exposure limit established     No exposure limit established

Appropriate Engineering Controls: Whenever possible the use of local exhaust ventilation or other engineering controls is the preferred method of controlling exposure to airborne dust and fume to meet established occupational exposure limits. Use good housekeeping and sanitation practices. Do not use tobacco or food in work area. Wash thoroughly before eating or smoking. Do not blow dust off clothing or skin with compressed air.

Individual Protection Measures, Such as Personal Protective Equipment:

   Respiratory Protection: Wear a NIOSH/MSHA approved respirator when dust or fumes are present.

   Eye Protection: Safety glasses

   Skin Protection: Wear impermeable gloves, protective work clothing as necessary.

 

 

9   PHYSICAL AND CHEMICAL PROPERTIES

Appearance:

  Form:                 Powder

  Color:                 Dark blue to black

Odor:                    Not determined

Odor Threshold:  Not determined

pH:                                               N/A

Melting Point:                              No data

Boiling Point:                               No data

Flash Point:                                 N/A

Evaporation Rate:                       N/A

Flammability:                              No data

Upper Flammable Limit:             No data

Lower Flammable Limit:             No data

Vapor Pressure:                          No data

Vapor Density:                             N/A

Relative Density (Specific Gravity):     No data

Solubility in H2O:                         Insoluble

Partition Coefficient (n-octanol/water):   Not determined

Autoignition Temperature:         No data

Decomposition Temperature:     No data

Viscosity:                                     N/A

 

 

10   STABILITY AND REACTIVITY

Reactivity: No specific test data available.

Chemical Stability: Stable under recommended storage conditions.

Possibility of Hazardous Reactions: Hazardous polymerization will not occur.

Conditions to Avoid: No data

Incompatible Materials: Strong oxidizing agents.

Hazardous Decomposition Products: Iridium oxide fumes.

 

 

11   TOXICOLOGICAL INFORMATION

Likely Routes of Exposure: Inhalation, skin and eyes.

Symptoms of Exposure: May cause irritation.

Acute and Chronic Effects:

Iridium Compounds:  In rare cases, occupational exposure to iridium salts may cause sensitization.

Acute Toxicity: No data

CarcinogenicityNTP:  Not identified as carcinogenic    IARC:  Not identified as carcinogenic

To the best of our knowledge the chemical, physical and toxicological characteristics of the substance are not fully known.

 

 

12   ECOLOGICAL INFORMATION

Ecotoxicity: No data

Persistence and Degradability: No data

Bioaccumulative Potential: No data

Mobility in Soil: No data

Other Adverse Effects: Do not allow material to be released to the environment. No further relevant information available.

 

 

13   DISPOSAL CONSIDERATIONS

Waste Disposal Method:

Product: Dispose of in accordance with Federal, State and Local regulations.

Packaging: Dispose of in accordance with Federal, State and Local regulations.

 

 

14   TRANSPORT INFORMATION

Shipping Regulations:  Not regulated

   UN Number:                           N/A

   UN Proper Shipping Name:   N/A

   Transport Hazard Class:       N/A

   Packing Group:                      N/A

   Marine Pollutant:                   No

 

 

15   REGULATORY INFORMATION

TSCA Listed: No  (hydrate is not listed but CAS# 12030-49-8, Iridium (IV) Oxide is listed)

DSL Listed: No  (hydrate is not listed but CAS# 12030-49-8, Iridium (IV) Oxide is listed)

Regulation (EC) No 1272/2008 (CLP): N/A

WHMIS 2015 Classification: N/A

HMIS RatingsHealth:  1     Flammability:  0     Physical:  0

NFPA RatingsHealth:  1     Flammability:  0     Instability:  0

Chemical Safety Assessment: A chemical safety assessment has not been carried out.

 

 

16   OTHER INFORMATION

The information contained in this document is based on the state of our knowledge at the time of publication and is believed to be correct, but does not purport to be all inclusive and shall be used only as a guide. ESPI Metals makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. ESPI Metals shall not be held liable for any damages resulting from handling or from contact with the above product. Users should satisfy themselves that they have all current data relevant to their particular use.

 

Prepared by:              ESPI Metals

Revised/Reviewed:    August 2017

Home Page Content Under Periodic Table

ALLOYS

Click on the Alloy to go to the Online Catalog page.

 

Welcome to

ESPI was incorporated in 1950 with a mission to provide a competitive source for high purity metals, metal compounds and alloys. We are a valuable resource for virtually all major universities worldwide, global corporate R&D laboratories, thousands of domestic and international manufacturing companies and all U.S. government research laboratories. ESPI offers unique advantages often unavailable from larger organizations with no minimum order size & all business hour calls are handled by a competent sales representative. Automated answering systems and voice mail are not an option at ESPI.

Located within our fabrication facility is the melting department, forging & shaping areas, and the rod & wire, and sheet & foil departments providing the following manufacturing capabilities:

  • Casting of pure metals and alloys
  • Vacuum arc melting
  • Induction melting
  • Rod and wire drawing/extrusion
  • Sheet, foil and ribbon rolling
  • CNC milling and machining

Tel: 541-488-8311 - Email: sales@espimetals.com - or click the "Live Help/Chat Now" icon, upper right.

 

FORMS

ESPI produces and sells 68 elements and dozens of alloys in various forms for your custom needs. Click on the forms below to be directed to detailed information on manufacturing.

 

 

At We Keep Good Company


Aerospace and Defense
Northrop Grumman, Hewlett Packard, IBM, Lockheed-Martin, Hughes, Boeing, General Dynamics, Aerojet, Litton, General Electric


Medical Instruments & Technology
Cintron, Hologic/Lorad, Varian, Siemens Medical, St Jude Medical, ArthroCare, GE Medical, Harvard Medical School, City of Hope Medical Center, American Medical Systems, Cedars Sinai Medical Center


International
Atomic Energy of Canada, CNRS, European Synchrotron Radiation Facility, INRS, Alberta Research Council, National Research Council of Canada, UNAM, CISRO, CERN


Education
Stanford, UCLA, Harvard, Georgia Institute of Technology, Caltech, Johns Hopkins University, University of Arizonia, Penn State, University of Michigan, Princeton, Yale, University of Wollongong, University of Tokoyo, University of Toronto, Tulane, University of New South Wales, Max-Planck Institute, University of Freiburg


Government Research Labs
JPL, Los Alamos National Lab, Battelle Pacific NW National Lab, US Department of Energy, Argonne National Lab, Brookhaven National Lab, Naval Oceans Systems Center, US Air Force, Lawrence Berkeley National Lab, NASA


Green Energy
Origin Energy Solar, First Solar, Schott Solar, SunPower Corporation, Nanosolar, Inc.